BCOP Updates
These modules are designed for practicing advanced level BCOP pharmacists. Covering new and ongoing therapeutic developments, these modules will provide you with up-to-date information, including recently published or ongoing studies from the past 2-3 years that you can immediately apply to your practice. Earn up to 9.0 hours of BCOP credit.
Individual Learning Opportunities
Clear filter
-
IndividualLearn more
BCOP Updates 2026: Updates in Cancer Pain Management
On-demand This session will provide an overview of the current landscape of cancer pain management, highlighting the differences between nociceptive, neuropathic, inflammatory, and treatment-related pain. -
IndividualLearn more
BCOP Updates 2026: Updates in Lung Cancer
On-demand The treatment landscape of lung cancer is constantly evolving to meet the needs of patients. This presentation will provide an overview of selected novel therapies used in both non-small cell and small cell lung cancers. -
IndividualLearn more
BCOP Updates 2026: Myth Busters: Hormone Replacement Therapy and Supplements in Breast and Gynecological Cancers
On-demand This session will explore the nuanced evidence of hormone replace therapy and the role in oncology, highlighting the delicate balance between symptom management and oncologic safety. -
IndividualLearn more
BCOP Updates 2026: How Low Should We Go? Incorporating Updates in HER2-Targeted Treatments for Metastatic Breast Cancer into Clinical Practice
On-demand This presentation will review the historical and recently updated HER2-testing paradigm as it relates to HER2-targeted treatment of metastatic breast cancer. -
IndividualLearn more
BCOP Updates 2026: Outpatient Administration of Desensitization Protocols, High-Dose Methotrexate, and Other Complex Therapies
On-demand This presentation aims to highlight current literature for outpatient administration of complex therapies, as well as real world tips for implementation in large and small cancer centers. -
IndividualLearn more
BCOP Updates 2026: Beyond Steroids: Updates in Chronic Graft-Versus-Host Disease
On-demand This session will focus on the four FDA-approved agents for the treatment of steroid-dependent or steroid-refractory cGVHD, emphasizing their organ system efficacy, place in therapy, mechanism of action, key drug interactions, and adverse event profiles. -
IndividualLearn more
BCOP Updates 2026: Stepping-Up Your Game: Outpatient Myeloma Bispecifics
On-demand Novel therapies such as bispecific antibodies and trispecific antibodies, harness immune effector cells to target clonal plasma cells leading to unpredecented levels of efficacy. However, this can also lead to a state of hyperinflammation, known as cytokine release syndrome. To mitigate this, patients are administered step up doses (SUD) with premedications while admitted to an inpatient facility. -
IndividualLearn more
BCOP Updates 2026: Supporting the War Against Cancer: Fighting Fatigue and Combating Cachexia
On-demand This session will review the underlying etiology, clinical presentation, diagnostic criteria, impact, and evidence-based strategies for assessment and management, including both pharmacologic and non-pharmacologic interventions, for cancer-related fatigue and cachexia. -
IndividualLearn more
BCOP Updates 2026: Don't Break My Heart: Cardio-monitoring and Prevention of Treatment-induced Cardiovascular Toxicity in Oncology
On-demand In this session the use of traditional cardiac monitoring tests compared to the most recent data driven recommendations on cardiac monitoring will be discussed. Pharmaco-therapeutic interventions that address chemotherapy and targeted therapy-related cardiovascular disease will be compared to highlight new strategies for treatment/prevention of cardiovascular toxicity.